Identification of hepatological and metabolical risk factors in patients with a ventricular assist device

• Conditions: Therapy refractory heart failure; Z95.80

• Registration Number: DRKS00004264
• Lead Sponsor: Medizinische Hochschule Hannover

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2013-01-31
• Study Start: 2014-03-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 61

Inclusion Criteria

Patients with an indication for the implantation of a ventricular assist device, written informed consent of the patient or a legally certain attendant

Exclusion Criteria

no indication for the implantation of a ventricular assist device, missing informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival after 100 days

Secondary Outcome Measures

Name	Time	Method
iver dysfunction defined as bilirubin >51 µmol/l, Albumin <28 g/l, ICG-PDR <10 %/min on POD 3 and 7.